Glens Falls Grand Strand Carrington Institutional Outsourced CIO & Wealth Advisory
Additional shared vehicles: Kayne Partners Growth Fund VI (2025 Vintage) · Kepe Selling Fund II (2025 Vintage)
$16.2B Total AUM · Institutional LP profile covering 25 historical fund disclosure records ($1.86B parsed USD across disclosed rows) across disclosed strategy exposure in Buyout, Venture Capital, Real Estate, Growth Equity, Energy Transition (investment geography mandates are evaluated separately from LP headquarters). 5 complete primary source trails are open below without registration.
Showing 5 open preview records out of 25 total tracked records (+20 gated pilot rows). Click Inspect Source on any row to view field-level substantiation, table headers/units, and archived page excerpts without login.
| Disclosed Fund / Vehicle | Strategy | Fund Vintage | Disclosed Amount | Disclosed Performance | Primary Source Trail |
|---|---|---|---|---|---|
| Khosla Ventures IX, LP | Venture Capital | 2025 |
$103.0M
Historical commitment · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · IRS Form 990 Sched D |
| Khosla Ventures Opportunities III, LP | Growth Equity | 2025 |
$89.8M
Historical commitment · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · IRS Form 990 Sched D |
| Kayne Partners Growth Fund VI | Growth Equity | 2025 |
$81.5M
Historical commitment · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · IRS Form 990 Sched D |
| Khosla Ventures IX. L.P. | Venture Capital | 2025 |
$44.8M
Historical commitment · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · IRS Form 990 Sched D |
| Kepe Selling Fund II | Energy Transition | 2025 |
$37.8M
Historical commitment · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · IRS Form 990 Sched D |
Tracked separately from historical commitments: active RFPs/searches, board pacing plans, leadership/CIO updates, and retained gatekeeper consultants.
Advocate Health (Atrium / Advocate Aurora) Investments (Healthcare / Hospital System, $16.2B AUM): Disclosed FY2025-2026 Private Markets Pacing & Allocation Update (PE Target 21.0% vs. 18.9% Actual; $340.2M Unallocated Target Bandwidth). IRS Form 990 Schedule D Verified (EIN 566060481, $16.20B long-term investment & endowment pool): Active commitments across healthcare buyout, biotech/medtech venture, mid-market PE, and private credit. Gatekeeper / Intake Conduit: NEPC.
Forward-looking board pacing or target-allocation policy update · Recorded 2025-04-10
Board-Approved Pacing Plans, Active RFPs & Target-vs-Actual Allocation Gap
Join waitlist for pacing dossier →
Retained Private Markets Advisors & Emerging-Manager Search Conduits
Join waitlist for consultant map →
CIO, Private Markets Officers & Official Pitch Intake Guidance
Join waitlist for team directory →
You are viewing 5 open public preview records (out of 25 total tracked records for Advocate Health (Atrium / Advocate Aurora) Investments) with zero-registration primary source trails. Join the early-access waitlist to request pilot access:
Enter your firm email to request pilot onboarding for Advocate Health (Atrium / Advocate Aurora) Investments and our interactive GP workspace.
Thank you for joining the Prilago early-access waitlist! We will reach out with pilot access details for your firm.
Advocate Health (Atrium / Advocate Aurora) Investments is categorized under Healthcare / Hospital System (Regional Roadshow Hub: Southeast (NC / GA / TN / SC / AL / KY / LA); Headquarters: Charlotte, NC). Across 25 historical disclosure records tracked on Prilago ($1.86B total parsed USD across disclosed rows), the median disclosed amount is $81.5M (range: $35.0M to $125.2M).
Advocate Health (Atrium / Advocate Aurora) Investments has disclosed records across Buyout, Venture Capital, Real Estate, Growth Equity, Energy Transition. Open preview records include Khosla Ventures IX, LP (2025 Vintage), Khosla Ventures Opportunities III, LP (2025 Vintage), Kayne Partners Growth Fund VI (2025 Vintage), Khosla Ventures IX. L.P. (2025 Vintage).
Records for Advocate Health (Atrium / Advocate Aurora) Investments cite primary public disclosures (IRS Form 990 Sched D), and visitors can inspect 5 open source trails on this profile without registration. Each source trail displays field-level substantiation status, distinguishing exact commitment schedules from carrying-value or fee tables. Forward-looking active searches, RFPs, pacing plans, and governance updates are separated from historical disclosures.
General Partners can join the early-access waitlist on https://prilago.com/lp/advocate-health-atrium-advocate-aurora-investments or test fund suitability in the interactive read-only demo at https://prilago.com/demo.
In Prilago's bilateral commitment graph, Advocate Health (Atrium / Advocate Aurora) Investments shares resolved underlying fund vehicles with 1,020 institutional LPs across 24 shared vehicles (shared fund exposure represents a potential introduction path and does not prove LPAC seat overlap or personal acquaintance). Top shared-fund peers include Glens Falls Grand Strand Carrington Institutional Outsourced CIO & Wealth Advisory (11 shared vehicles, e.g. Khosla Ventures IX, LP (2025 Vintage)), Cocheco Cowlitz Kensington Mutual & Casualty Insurance General Account (11 shared vehicles, e.g. Khosla Ventures Opportunities III, LP (2025 Vintage)), Highlands Cherokee Strip Gallagher Private Markets Primary & GP Seeder Fund-of-Funds (11 shared vehicles, e.g. Kayne Partners Growth Fund VI (2025 Vintage)).